东威科技(688700) - 2021 Q3 - 季度财报

Financial Performance - The company's operating revenue for Q3 2021 was ¥214,609,006.17, representing a year-on-year increase of 17.71%[8] - The net profit attributable to shareholders for Q3 2021 was ¥41,652,631.31, reflecting a year-on-year growth of 24.11%[8] - The total revenue from the beginning of the year to the end of the reporting period reached ¥563,983,437.53, marking a significant increase of 58.19% compared to the same period last year[8] - The net profit attributable to shareholders after deducting non-recurring gains and losses for the year-to-date was ¥107,311,063.92, up 131.80% year-on-year[12] - Total operating revenue for the first three quarters of 2021 reached ¥563,983,437.53, a significant increase of 58.2% compared to ¥356,533,629.87 in the same period of 2020[37] - Operating profit for the first three quarters of 2021 was ¥124,503,510.08, up 101.0% from ¥61,686,257.62 in the previous year[39] - Net profit for the first three quarters of 2021 was ¥110,950,964.72, representing a 106.8% increase compared to ¥53,632,111.18 in the same period of 2020[39] - Basic and diluted earnings per share for the first three quarters of 2021 were both ¥0.90, compared to ¥0.49 in the same period of 2020[43] Research and Development - Research and development expenses totaled ¥16,105,440.00 in Q3 2021, a substantial increase of 101.52% compared to the same period last year[12] - The company has initiated multiple new R&D projects to expand market space, leading to increased R&D material consumption and costs[16] - Research and development expenses for the first three quarters of 2021 were ¥41,769,333.14, significantly higher than ¥23,082,922.09 in the previous year, indicating a focus on innovation[37] Assets and Liabilities - The total assets at the end of the reporting period were ¥1,385,943,730.43, which is a 61.45% increase from the end of the previous year[12] - The equity attributable to shareholders reached ¥718,871,456.37, reflecting a 100.78% increase year-on-year[12] - Total current assets as of September 30, 2021, amounted to RMB 1,244,491,312.63, compared to RMB 739,459,642.14 as of December 31, 2020[32] - Total assets as of September 30, 2021, reached RMB 1,385,943,730.43, up from RMB 858,437,959.25 as of December 31, 2020[34] - Total liabilities as of September 30, 2021, were RMB 667,072,274.06, compared to RMB 500,407,408.43 as of December 31, 2020[34] - The company's equity attributable to shareholders as of September 30, 2021, was RMB 718,871,456.37, an increase from RMB 358,030,550.82 as of December 31, 2020[34] Cash Flow - The net cash flow from investing activities increased by 1018.83% from the beginning of the year to the end of the reporting period, mainly due to an increase in the purchase of financial products[27] - The net cash flow from financing activities increased by 1003.71% from the beginning of the year to the end of the reporting period, primarily due to the completion of public issuance of shares on the Sci-Tech Innovation Board in June 2021[27] - Cash flow from operating activities for the first three quarters of 2021 was ¥32,072,788.94, an increase from ¥23,250,222.53 in the previous year[46] - Cash inflow from investment activities totaled ¥263,610,315.25, compared to ¥6,189,650.00 in the same period of 2020[46] - Cash outflow from investment activities was ¥606,764,093.06, resulting in a net cash flow from investment activities of -¥343,153,777.81[46] - The company received cash from investment totaling ¥262,000,000.00 during the first three quarters of 2021[46] - Total cash inflow from financing activities amounted to $313,428,000[48] - Cash outflow from financing activities totaled $60,769,418.49, compared to $27,958,000 in the previous period[48] - Net cash flow from financing activities was $252,658,581.51, a significant increase from -$27,958,000 in the prior period[48] - The net increase in cash and cash equivalents was -$58,597,186.53, compared to -$35,567,264.28 previously[48] - The ending balance of cash and cash equivalents stood at $87,314,198.22, up from $83,163,622.78 in the previous period[48] Accounts Receivable and Payable - Accounts receivable increased by 40.42% from the beginning of the year to the end of the reporting period, mainly due to an increase in sales orders and revenue[24] - The increase in notes payable was 92.49% from the beginning of the year to the end of the reporting period, mainly due to an increase in procurement payments settled by notes[27] - The company's cash and cash equivalents decreased from RMB 145,916,888.67 at the end of 2020 to RMB 87,314,198.22 by September 30, 2021[28]